The Journal of Experimental Medicine
PBL InterferonSource
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 10 April 2000.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 274K)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maini, M. K.
Right arrow Articles by Bertoletti, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maini, M. K.
Right arrow Articles by Bertoletti, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1007/2000/4/1269/ $5.00
The Journal of Experimental Medicine, Volume 191, Number 8, April 17, 2000 1269-1280


Original Article

The Role of Virus-specific CD8+ Cells in Liver Damage and Viral Control during Persistent Hepatitis B Virus Infection

Mala K. Mainia,b, Carolina Bonic, Chun Kyon Leea, Juan R. Larrubiaa, Stephanie Reignata, Graham S. Oggd, Abigail S. Kingd, Jethro Herberga, Richard Gilsonb, Akeem Alisae, Roger Williamsa, Diego Vergania, Nikolai V. Naoumova, Carlo Ferraric, and Antonio Bertolettia
a Institute of Hepatology, University College London and University College of London Hospitals, London WC1E 6HX, United Kingdom
b Department of Sexually Transmitted Diseases, University College London and University College of London Hospitals, London WC1E 6HX, United Kingdom
c Laboratorio Immunopatologia Virale, Ospedale di Parma, 43100 Parma, Italy
d Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom
e Cromwell Hospital, London SW5 0TU, United Kingdom

Correspondence to: Antonio Bertoletti, Institute of Hepatology, University College London, 69-75 Chenies Mews, London WC1E 6HX, UK. Tel:44-171-209-6516 Fax:44-171-380-0405 E-mail:a.bertoletti{at}ucl.ac.uk.

Hepatitis B virus (HBV) is a noncytopathic virus, and the recognition of infected hepatocytes by HBV-specific CD8 cells has been assumed to be the central mechanism causing both liver damage and virus control. To understand the role of cytotoxic T cells in the pathogenesis of HBV infection, we used functional assays that require T cell expansion in vitro and human histocompatibility leukocyte antigen (HLA)-peptide tetramers that allow direct ex vivo quantification of circulating and liver-infiltrating HBV-specific CD8 cells. Two groups of patients with persistent HBV infection were studied: one without liver inflammation and HBV replication, the other with liver inflammation and a high level of HBV replication. Contrary to expectation, a high frequency of intrahepatic HBV-specific CD8 cells was found in the absence of hepatic immunopathology. In contrast, virus-specific T cells were more diluted among liver infiltrates in viremic patients, but their absolute number was similar because of the massive cellular infiltration. Furthermore, inhibition of HBV replication was associated with the presence of a circulating reservoir of CD8+ cells able to expand after specific virus recognition that was not detectable in highly viremic patients with liver inflammation.

These results show that in the presence of an effective HBV-specific CD8 response, inhibition of virus replication can be independent of liver damage. When the HBV-specific CD8 response is unable to control virus replication, it may contribute to liver pathology not only directly but by causing the recruitment of nonvirus-specific T cells.

Key Words: hepatitis, tetramers, antiviral cytotoxic T lymphocytes, cell migration, immunopathology


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS